Hansa Medical AB to change name to Hansa Biopharma AB
The name change will be implemented in the next days and weeks and the Company stock ticker symbol has changed from “HMED” to “HNSA”.
The information was submitted for publication, through the agency of the contact person set out below, at 2:15 pm CET on December 20, 2018.
For further information, please contact:
Emanuel Björne, Vice President Business Development and Investor Relations, Hansa Medical AB (publ)
Mobile: +46 707 175477
Swedish Investor and Media Relations:
+46 70-311 99 60
U.K. Investor and Media Relations
Simon Conway/ Stephanie Cuthbert
+44 (0)20 3727 1000
U.S. Investor and Media Relations:
Stephanie Marks/ David Rosen (media)
+1 212 600 1902